Insider Transactions Reported by 19 Insiders of Rapport Therapeutics, Inc.

Symbol
RAPP on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

Rapport Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Third Rock Ventures V, L.P. 10%+ Owner $80,882,421 10 Jun 2024
ARCH Venture Partners XII, LLC 10%+ Owner $37,212,805 10 Jun 2024
Abraham Ceesay Chief Executive Officer, Director $20,920,529 -$2,891,482 -12% 17 Dec 2025
JAMES HEALY Director $19,916,028 17 Jun 2025
David Bredt Chief Scientific Officer $12,045,157 -$1,488,793 -11% 15 Dec 2025
Cheryl Gault Chief Operating Officer $5,174,568 -$150,487 -2.8% 26 Nov 2025
Krishnaswamy Yeleswaram Chief Development Officer $2,902,493 03 Feb 2025
Bradley S. Galer Chief Medical Officer $1,970,311 06 Jun 2024
STEVEN M. PAUL Director $1,040,450 +$1,027,111 +7700% 12 Sep 2025
Reid M. Huber Director $499,373 +$499,374 12 Sep 2025
Wendy B. Young Director $214,700 +$140,350 +189% 11 Sep 2025
Troy A. Ignelzi Chief Financial Officer $99,800 +$100,988 12 Mar 2025
JOHN MARAGANORE Director 17 Jun 2025
ROBERT J. PEREZ Director 17 Jun 2025
Ramiro Sanchez Director 17 Jun 2025
Paul M. Silva Director 17 Jun 2025
Jeffrey Sevigny Chief Medical Officer 01 Apr 2025
Jeffrey K. Tong Director 06 Jun 2024
Terry-Ann Burrell Director 06 Jun 2024

Recent Insider Transactions by Companies or Individuals for Rapport Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.